Quantum Cyber N.V. (QUCY) AI Stock Summary

Snapshot

The ticker QUCY is a shell. The listed entity is Mainz Biomed, a German cancer diagnostic firm that generated only $537,000 in revenue last year and lost $16.2 million. It holds just $889,000 in cash against $2.6 million in debt, leaving it with a tight financial position. Meanwhile, the news feed and recent filings describe a completely different company called Quantum Cyber, an autonomous defense firm that just raised $15 million and is building drone factories. The financial data for the listed shell shows a business that is shrinking and burning cash, while the news describes a separate, well-funded operation. This disconnect suggests the listed stock is a vehicle for a reverse merger or acquisition, not a standalone operating business.

What's Happening Right Now

• Mon 8th Jun '26 · Acquisition: The company signed a letter of intent to buy a 43,000-square-foot manufacturing facility in Connecticut for $3.2 million.
• Tue 26th May '26 · Financing: Quantum Cyber raised over $15 million by having investors exercise warrants, using the cash to pay off all debt.
• Mon 18th May '26 · Strategy: Quantum Cyber launched a new subsidiary called Quantum Drones Corporation to handle U.S. federal defense contracts.

Bottom Line

This is not a normal stock. The financial statements belong to a tiny, failing German biotech firm, but the news headlines belong to a U.S. defense contractor called Quantum Cyber. The listed entity has almost no cash and is losing money fast, which is a serious red flag. The recent news about raising $15 million and buying factories applies to the defense company, not the listed shell. Until the two entities are legally combined and the financials reflect the defense business, this stock is a speculative bet on a corporate restructuring, not an investment in a working company.